首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

亞太地區藥品合約銷售組織市場預測至 2030 年 - 區域分析 - 按服務、模組、治療領域和最終用戶

市場調查報告書

商品編碼

1494469

亞太地區藥品合約銷售組織市場預測至 2030 年 - 區域分析 - 按服務、模組、治療領域和最終用戶

Asia Pacific Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User

出版日期: 2024年04月05日 | 出版商:

The Insight Partners | 英文 88 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

亞太地區藥品合約銷售組織市場預計將從2022年的17.0748億美元成長到2030年的36.4688億美元。

遠距醫療和遠距詳細資訊的使用不斷增加推動亞太地區藥品合約銷售組織市場

遠距醫療和遠距詳細資訊的日益普及為藥品合約銷售組織 (CSO) 市場帶來了新的機會。數位健康科技的變革性影響重新定義了醫病互動，並徹底改變了藥品銷售的動態。遠距醫療具有促進虛擬諮詢和參與的能力，為公民社會組織的適應和創新創造了肥沃的土壤。遠端詳細資訊涉及使用數位管道傳達產品資訊並吸引醫療保健專業人員，成為公民社會組織擴大影響範圍的策略途徑。這項策略變化凸顯了製藥業為應對市場複雜性所採取的積極主動的方法。透過與公民社會組織合作，這些企業可以接觸到專業銷售人員，利用外部專業知識來提高市場滲透率並提高銷售效率。透過這種協作模式，製藥公司可以簡化其營運並專注於研發等關鍵能力，同時利用公民社會組織的特定知識來提高其產品的適銷性。製藥公司和民間社會組織之間不斷加強的合作表明了對適應的奉獻精神以及對競爭激烈的製藥行業發展動態的深刻把握。它也顯示了對資源最佳化的細緻入微的理解。這種互惠互利的合作關係使收入最大化成為可能，並從戰略上將製藥公司置於適應性和針對性強的市場策略對於長期成功至關重要的市場中。

亞太地區藥品合約銷售組織市場概況

近年來，由於對具有成本效益的銷售和行銷解決方案的需求不斷增加，亞太地區藥品合約銷售組織市場經歷了顯著成長。儘管這些國家對醫療保健產品的需求很大，但製藥公司在進入中國、印度和日本等國家的多元化和偏遠市場方面面臨挑戰。透過將銷售和行銷職能外包給公民社會組織，公司可以從專業團隊的專業知識中受益，而無需大量的基礎設施和人員投資。此外，亞太地區慢性病的增加和人口老化的加劇也促進了藥品合約銷售組織市場的擴大。

數位技術的可用性和採用率不斷提高，以及對大量資料來源的輕鬆訪問，使製藥 CSO 能夠收集和分析即時資料，從而幫助其客戶使用可行的見解。 2023年4月，賽諾菲中國採用了可擴展的商業無所不在的CRM解決方案，該解決方案將適應其不斷發展、動態的業務模式，從而加速數位化轉型，並使公司能夠繼續致力於創新。 Omnipresence CRM 使用先進的分析、資料來源和機器學習來產生見解、支援更好的決策，並為商業團隊創造新的機會，以提高敏捷性來加速取得成果。

亞太地區藥品合約銷售組織市場收入及 2030 年預測（百萬美元）

亞太地區藥品合約銷售組織市場區隔

亞太地區藥品合約銷售組織市場分為服務、模組、治療領域、最終用戶和國家。

根據服務，亞太地區藥品合約銷售組織市場分為商業服務和非商業服務。 2022年，商業服務領域在亞太藥品合約銷售組織市場中佔據更大佔有率。

根據模組，亞太地區藥品合約銷售組織市場分為聯合模組和專用模組。 2022 年，聯合模組細分市場在亞太地區藥品合約銷售組織市場中佔據更大佔有率。

根據治療領域，亞太地區藥品合約銷售組織市場分為心血管疾病、腫瘤、代謝性疾病、神經病學、骨科疾病、傳染病等。 2022 年，腫瘤學領域在亞太藥品合約銷售組織市場中佔據最大佔有率。

根據最終用戶，亞太地區藥品合約銷售組織市場分為生物製藥公司和製藥公司。 2022 年，製藥公司細分市場在亞太地區藥品合約銷售組織市場中佔有更大佔有率。

按國家/地區分類，亞太地區藥品合約銷售組織市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年，中國在亞太藥品合約銷售組織市場佔據主導地位。

Aenova Holding GmbH、CMIC Holdings Co Ltd、EPS Holdings Inc、IQVIA Holdings Inc、Mednext Pharmaceuticals Pvt Ltd、輝瑞 Inc 和 Syneos Health Inc 是亞太地區藥品合約銷售組織市場上的一些領先公司。

The increasing use of telemedicine and remote detailing leads to new opportunities for the pharmaceutical contract sales organization (CSO) market. The transformative influence of digital health technologies has redefined patient-doctor interactions and revolutionized the dynamics of pharmaceutical sales. With its capacity to facilitate virtual consultations and engagements, telemedicine creates a fertile ground for CSOs to adapt and innovate. Remote detailing, which involves using digital channels to communicate product information and engage healthcare professionals, becomes a strategic avenue for CSOs to extend their reach. This strategic change highlights the pharmaceutical industry's proactive approach to navigating the market's complexity. By working with CSOs, these businesses can access specialist sales personnel, leveraging outside expertise to increase market penetration and improve sales effectiveness. Through this collaborative model, pharmaceutical companies may streamline their operations and concentrate on key capabilities like research and development while utilizing the specific knowledge of CSOs to increase the marketability of their products. The rising cooperation between pharmaceutical corporations and CSOs demonstrates a dedication to adaptation and a profound grasp of the developing dynamics within the very competitive pharmaceutical industry. It also displays a nuanced understanding of resource optimization. This mutually beneficial partnership makes revenue maximization possible and strategically places pharmaceutical firms in a market where adaptability and focused market strategies are essential for long-term success.

Asia Pacific Pharmaceutical Contract Sales Organizations Market Overview

The Asia Pacific pharmaceutical contract sales organization market has experienced significant growth in recent years owing to the elevated demand for cost-effective sales and marketing solutions. Pharmaceutical companies face the challenge of reaching diverse and remote markets in countries such as China, India, and Japan, despite a significant demand for healthcare products in these countries. By outsourcing sales and marketing functions to CSOs, the companies can benefit from the expertise of specialized teams without the need for extensive infrastructure and personnel investments. Furthermore, the rise in chronic diseases and the growing aging population in the Asia Pacific region have also contributed to the expansion of the pharmaceutical contract sales organization market.

The increasing availability and adoption of digital technologies, and easy access to a large number of data sources allow pharmaceutical CSOs to gather and analyze real-time data, thereby assisting their clients with the use of actionable insights. In April 2023, SANOFI China adopted a scalable, commercial omnipresence CRM solution that would adapt to its evolving, dynamic business model, thereby accelerating digital transformation and allowing the company to continue working toward innovation. Omnipresence CRM uses advanced analytics, data sources, and machine learning to generate insights, support better decision-making, and create new opportunities for commercial teams to speed up results with increased agility.

Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation

The Asia Pacific pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.

Based on services, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on modules, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on therapeutic area, the Asia Pacific pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on end user, the Asia Pacific pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Based on country, the Asia Pacific pharmaceutical contract sales organizations market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific pharmaceutical contract sales organizations market in 2022.

Aenova Holding GmbH, CMIC Holdings Co Ltd, EPS Holdings Inc, IQVIA Holdings Inc, Mednext Pharmaceuticals Pvt Ltd, Pfizer Inc, and Syneos Health Inc are some of the leading companies operating in the Asia Pacific pharmaceutical contract sales organizations market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis

5. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing Integration of Digital Technologies
- 5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
- 5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
- 5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
- 5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Asia Pacific Market Analysis

6.1 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview
7.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
- 7.3.1 Overview
- 7.3.2 Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
- 7.4.1 Overview
- 7.4.2 Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview
8.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
- 8.3.1 Overview
- 8.3.2 Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
- 8.4.1 Overview
- 8.4.2 Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview
9.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
- 9.3.1 Overview
- 9.3.2 Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
- 9.4.1 Overview
- 9.4.2 Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
- 9.5.1 Overview
- 9.5.2 Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
- 9.6.1 Overview
- 9.6.2 Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
- 9.7.1 Overview
- 9.7.2 Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
- 9.8.1 Overview
- 9.8.2 Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
- 9.9.1 Overview
- 9.9.2 Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
- 10.3.1 Overview
- 10.3.2 Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
- 10.4.1 Overview
- 10.4.2 Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 Asia Pacific

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview
12.2 Growth Strategies
- 12.2.1 Overview

13. Company Profiles

13.1 CMIC Holdings Co Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 EPS Holdings Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 IQVIA Holdings Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Syneos Health Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Mednext Pharmaceuticals Pvt Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Aenova Holding GmbH
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
13.7 Pfizer Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 20. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 21. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 27. Glossary of Terms, Asia Pacific Pharmaceutical Contract Sales Organizations Market

List Of Figures

Figure 1. Asia Pacific Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. Asia Pacific - PEST Analysis
Figure 3. Asia Pacific Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: Asia Pacific Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 24. Asia Pacific Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. China: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Japan: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. India: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Australia: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. South Korea: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Rest of Asia Pacific: Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)